pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

398 catalysts · 3,189 8k filing · 577 earnings · 231 grant · 172 phase 2 completion · 167 approval · 133 drug shortage

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-08-10: 0 catalysts2026-08-11: 0 catalysts2026-08-12: 0 catalysts2026-08-13: 19 catalysts2026-08-14: 4 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 1 catalyst2026-08-18: 2 catalysts2026-08-19: 3 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 1 catalyst2026-08-27: 1 catalyst2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 1 catalyst2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 2 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 2 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 1 catalyst2026-10-14: 1 catalyst2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 1 catalyst2026-10-20: 2 catalysts2026-10-21: 2 catalysts2026-10-22: 2 catalysts2026-10-23: 1 catalyst2026-10-24: 0 catalysts2026-10-25: 0 catalysts2026-10-26: 1 catalyst2026-10-27: 8 catalysts2026-10-28: 12 catalysts2026-10-29: 21 catalysts2026-10-30: 4 catalysts2026-10-31: 0 catalysts2026-11-01: 0 catalysts2026-11-02: 9 catalysts2026-11-03: 18 catalysts2026-11-04: 22 catalysts2026-11-05: 37 catalysts2026-11-06: 2 catalysts2026-11-07: 0 catalysts2026-11-08: 0 catalysts
view
agendamonth
sort
soonestlatesttypesponsoralpha
type: grant×type: approval×from 2026-04-03×clear all
type
  • 8k filing3,189
  • earnings577
  • grant231
  • phase 2 completion172
  • approval167
  • drug shortage133
device 510k
101
  • phase 1 completion73
  • phase 2 initiation62
  • recall53
  • therapy area

    no tagged catalysts yet

    Week of Mar 30, 2026

    32
    ›Apr 3, 2026approval132d agoGLYCOPYRRONIUM TOSYLATE — FDA approvalJourney Medical Corp

    Sponsor: PADAGIS US. Form: CLOTH. Route: TOPICAL

    full page →fda approvals ↗
    ›Apr 3, 2026approval132d agoPHENYLEPHRINE HYDROCHLORIDE — FDA approvalPHENYLEPHRINE HYDROCHLORIDE

    Sponsor: BAXTER HLTHCARE CORP. Form: SOLUTION. Route: INTRAVENOUS

    full page →PHENYLEPHRINE HYDROCHLORIDE →fda approvals ↗
    ›Apr 3, 2026approval132d agoTYVASO (TREPROSTINIL) — FDA approvalUNITED THERAPEUTICS Corp

    Sponsor: UNITED THERAP. Form: SOLUTION. Route: INHALATION

    full page →fda approvals ↗
    ›Apr 3, 2026approval132d agoONDANSETRON HYDROCHLORIDE — FDA approvalRedHill Biopharma Ltd.

    Sponsor: PHARM ASSOC. Form: SOLUTION. Route: ORAL

    full page →fda approvals ↗
    ›Apr 3, 2026grant132d agoOHIO STATE UNIVERSITY — A high-throughput, multimodal strategy to improve variant classification

    HG grant. $174,430. PI: Megan Lancaster

    full page →nih reporter ↗
    ›Apr 3, 2026grant132d agoDUKE UNIVERSITY — Mentoring in Anti-Infective Clinical Pharmacology and PharmacometricsDuke University

    AI grant. $203,556. PI: Daniel Gonzalez

    full page →nih reporter ↗
    ›Apr 3, 2026grant132d agoUNIVERSITY OF NOTRE DAME — Species-specific Yeast RNAi Pesticides for Sand Fly Control

    AI grant. $464,176. PI: MARY A MCDOWELL

    full page →nih reporter ↗
    ›Apr 3, 2026grant132d agoWASHINGTON UNIVERSITY — An in vitro screening system for genitalia development

    ES grant. $419,676. PI: Liang Ma

    full page →nih reporter ↗
    ›Apr 3, 2026grant132d agoSLOAN-KETTERING INST CAN RESEARCH — Role of Arid1a in NK cell development and antiviral immunity

    AI grant. $46,564. PI: Mariah Lee

    full page →nih reporter ↗
    ›Apr 3, 2026grant132d agoWAYNE STATE UNIVERSITY — Mechanisms underlying Phage-Antibiotic Synergy and Resistance in Daptomycin-R...Baxter Healthcare Corp

    AI grant. $455,719. PI: Michael Joseph Rybak

    full page →nih reporter ↗
    ›Apr 3, 2026grant132d agoUNIVERSITY OF MIAMI SCHOOL OF MEDICINE — Beginning genetic interventions in infants (BEGIN)

    HG grant. $3,151,302. PI: PANKAJ B AGRAWAL

    full page →nih reporter ↗
    ›Apr 3, 2026grant132d agoUNIVERSITY OF COLORADO — Understanding mechanisms of RNA polymerase II transcriptional termination

    GM grant. $307,854. PI: James Goodrich

    full page →nih reporter ↗
    ›Apr 3, 2026grant132d agoCINCINNATI CHILDRENS HOSP MED CTR — Predictive approaches to mitigate risk of hepatotoxicity of drugs in children

    HD grant. $445,500. PI: Bhagwat Prasad

    full page →nih reporter ↗
    ›Apr 3, 2026grant132d agoNORTHWESTERN UNIVERSITY AT CHICAGO — Role of mRNA internal 2′-O methylation in post-transcriptional regulationNorthwestern University

    GM grant. $440,000. PI: Yang Yi

    full page →nih reporter ↗
    ›Apr 3, 2026grant132d agoMASSACHUSETTS GENERAL HOSPITAL — Endorsed ISMRM Workshop on MRI of NeuromodulationMassachusetts General Hospital

    EB grant. $10,000. PI: Lucia Isabel Navarro de Lara

    full page →nih reporter ↗
    ›Apr 3, 2026grant132d agoUNIVERSITY OF WISCONSIN-MADISON — Hijacking the neonatal Fc receptor: the novel biology of arterivirus entry, t...

    AI grant. $615,446. PI: Adam Lee Bailey

    full page →nih reporter ↗
    ›Apr 3, 2026grant132d agoWISTAR INSTITUTE — Myeloid cell-derived interleukin 1b promotes chemoresistance in metastatic ov...

    CA grant. $473,624. PI: Nan Zhang

    full page →nih reporter ↗
    ›Apr 3, 2026grant132d agoUNIVERSITY OF TEXAS AT AUSTIN — CD44 splice variants as novel antibody-targets for advanced breast cancer

    CA grant. $668,878. PI: JENNIFER A MAYNARD

    full page →nih reporter ↗
    ›Apr 3, 2026grant132d agoUNIVERSITY OF COLORADO — Regulatory nucleic acid interactions and telomere complexes

    GM grant. $495,480. PI: DEBORAH S. WUTTKE

    full page →nih reporter ↗
    ›Apr 3, 2026grant132d agoDREXEL UNIVERSITY — Investigating the Role of Phthalates, Phenols, and Their Sources on Phenotypi...

    ES grant. $111,199. PI: Marisa Ann Patti

    full page →nih reporter ↗
    ›Apr 3, 2026grant132d agoPENNSYLVANIA STATE UNIV HERSHEY MED CTR — An Assay for Paenibacillus Detection in Low Resourced Settings

    AI grant. $267,704. PI: JAMES R. BROACH

    full page →nih reporter ↗
    ›Apr 3, 2026grant132d agoINDIANA UNIVERSITY INDIANAPOLIS — Dissecting the impact of gut evolution on Klebsiella pneumoniae pathogenesis.

    AI grant. $435,875. PI: Jay Vornhagen

    full page →nih reporter ↗
    ›Apr 3, 2026grant132d agoUNIVERSITY OF ALABAMA AT BIRMINGHAM — Impact of regulatory dendritic cells in neonatal immune responses to Influen...

    AI grant. $490,611. PI: Aaron Silva-Sanchez

    full page →nih reporter ↗
    ›Apr 3, 2026grant132d agoUNIVERSITY OF CALIFORNIA LOS ANGELES — Indoor and Outdoor Exposure to LA Urban Wildfire Smoke – A Nature Experiment ...University of California Los Angeles

    ES grant. $354,375. PI: YIFANG ZHU

    full page →nih reporter ↗
    ›Apr 4, 2026grant131d agoPENNSYLVANIA STATE UNIVERSITY, THE — Environmental PFAS alter microbial function, impair host metabolism, and driv...

    ES grant. $2,864,424. PI: Jordan Adam Bisanz

    full page →nih reporter ↗
    ›Apr 5, 2026grant130d agoWASHINGTON STATE UNIVERSITY — Capturing Isomeric Heterogeneity and Structural Dynamics Using Transformative...

    GM grant. $406,037. PI: Brian Clowers

    full page →nih reporter ↗
    ›Apr 5, 2026grant130d agoUNIVERSITY OF NEBRASKA MEDICAL CENTER — Biological roles and mechanisms of cell surface RNAs in human papillomavirus ...

    GM grant. $417,845. PI: Jian Xie

    full page →nih reporter ↗
    ›Apr 5, 2026grant130d agoUNIVERSITY OF NORTH TEXAS — Advancing Digital Health Technology: A Summer Research Program for High Schoo...

    EB grant. $134,902. PI: Mark Vincent Albert

    full page →nih reporter ↗
    ›Apr 5, 2026grant130d agoUNIVERSITY OF MISSOURI-COLUMBIA — Advancing mechanistic understanding at membrane interfaces

    GM grant. $418,822. PI: Gavin McLean King

    full page →nih reporter ↗
    ›Apr 5, 2026grant130d agoUNIV OF NORTH CAROLINA CHAPEL HILL — Elucidating the Molecular Determinants of Functional Specificity in Intrinsic...

    GM grant. $413,946. PI: Rebecca Beth Berlow

    full page →nih reporter ↗
    ›Apr 5, 2026grant130d agoPURDUE UNIVERSITY — Systematic evaluation of competition between dsRNA binding proteins

    GM grant. $412,632. PI: Kyle Cottrell

    full page →nih reporter ↗
    ›Apr 5, 2026grant130d agoGORDON RESEARCH CONFERENCES — 2026 Image Science Gordon Research Conference and Gordon Research Seminar

    EB grant. $10,000. PI: Mini Das

    full page →nih reporter ↗

    Week of Apr 6, 2026

    18
    ›Apr 6, 2026approval129d agoIMATINIB MESYLATE — FDA approvalInhibikase Therapeutics, Inc.

    Sponsor: EUGIA PHARMA. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Apr 6, 2026approval
    ← prev
    page 1 of 8
    next →
    129d ago
    IMATINIB MESYLATE — FDA approvalInhibikase Therapeutics, Inc.

    Sponsor: EUGIA PHARMA. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Apr 6, 2026approval129d agoKEYTRUDA (PEMBROLIZUMAB) — FDA approvalpembrolizumab

    Sponsor: MERCK SHARP DOHME. Form: SOLUTION. Route: INTRAVENOUS

    full page →pembrolizumab →fda approvals ↗
    ›Apr 6, 2026approval129d agoDAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE (DAPAGLIFLOZIN) — FDA approvalDAPAGLIFLOZIN

    Sponsor: MICRO LABS. Form: TABLET, EXTENDED RELEASE. Route: ORAL

    full page →DAPAGLIFLOZIN →fda approvals ↗
    ›Apr 6, 2026approval129d agoDAPAGLIFLOZIN — FDA approvalDAPAGLIFLOZIN

    Sponsor: MICRO LABS. Form: TABLET. Route: ORAL

    full page →DAPAGLIFLOZIN →fda approvals ↗
    ›Apr 6, 2026approval129d agoDAPAGLIFLOZIN — FDA approvalDAPAGLIFLOZIN

    Sponsor: AUROBINDO PHARMA. Form: TABLET. Route: ORAL

    full page →DAPAGLIFLOZIN →fda approvals ↗
    ›Apr 6, 2026approval129d agoDAPAGLIFLOZIN — FDA approvalDAPAGLIFLOZIN

    Sponsor: BIOCON PHARMA. Form: TABLET. Route: ORAL

    full page →DAPAGLIFLOZIN →fda approvals ↗
    ›Apr 6, 2026approval129d agoDAPAGLIFLOZIN — FDA approvalDAPAGLIFLOZIN

    Sponsor: MSN. Form: TABLET. Route: ORAL

    full page →DAPAGLIFLOZIN →fda approvals ↗
    ›Apr 6, 2026approval129d agoDAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE (DAPAGLIFLOZIN) — FDA approvalDAPAGLIFLOZIN

    Sponsor: MSN. Form: TABLET, EXTENDED RELEASE. Route: ORAL

    full page →DAPAGLIFLOZIN →fda approvals ↗
    ›Apr 6, 2026approval129d agoDAPAGLIFLOZIN — FDA approvalDAPAGLIFLOZIN

    Sponsor: AJANTA PHARMA LTD. Form: TABLET. Route: ORAL

    full page →DAPAGLIFLOZIN →fda approvals ↗
    ›Apr 6, 2026approval129d agoDAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE (DAPAGLIFLOZIN, METFORMIN HYDROCHLORIDE) — FDA approvalDAPAGLIFLOZIN

    Sponsor: AUROBINDO PHARMA. Form: TABLET

    full page →DAPAGLIFLOZIN →fda approvals ↗
    ›Apr 6, 2026approval129d agoDAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE (DAPAGLIFLOZIN) — FDA approvalMicro Labs Ltd

    Sponsor: SUN PHARM. Form: TABLET, EXTENDED RELEASE. Route: ORAL

    full page →fda approvals ↗
    ›Apr 6, 2026approval129d agoDAPAGLIFLOZIN — FDA approvalMSN Pharmaceuticals Inc

    Sponsor: INVENTIA. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Apr 6, 2026approval129d agoDAPAGLIFLOZIN — FDA approvalDAPAGLIFLOZIN

    Sponsor: MACLEODS PHARMS LTD. Form: TABLET. Route: ORAL

    full page →DAPAGLIFLOZIN →fda approvals ↗
    ›Apr 6, 2026approval129d agoDAPAGLIFLOZIN — FDA approvalMSN Pharmaceuticals Inc

    Sponsor: AIZANT. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Apr 6, 2026approval129d agoKEYTRUDA QLEX (PEMBROLIZUMAB) — FDA approval(berahyaluronidase alfa + pembrolizumab)

    Sponsor: MERCK SHARP DOHME. Form: INJECTABLE. Route: INJECTION

    full page →(berahyaluronidase alfa + pembrolizumab) →fda approvals ↗
    ›Apr 6, 2026approval129d agoDAPAGLIFLOZIN — FDA approvalDAPAGLIFLOZIN

    Sponsor: LUPIN LTD. Form: TABLET. Route: ORAL

    full page →DAPAGLIFLOZIN →fda approvals ↗
    ›Apr 6, 2026approval129d agoDAPAGLIFLOZIN AND SAXAGLIPTIN HYDROCHLORIDE (DAPAGLIFLOZIN) — FDA approvalDAPAGLIFLOZIN

    Sponsor: MSN. Form: TABLET. Route: ORAL

    full page →DAPAGLIFLOZIN →fda approvals ↗
    $DERM6.4300+1.74%
    $IKT2.4000-2.04%
    $RDHL0.7390+6.64%
    $UTHR511.72-0.73%
    $IKT2.4000-2.04%